Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: Preliminary results

BJU International

Volumn 93, Issue 1, 2004, Pages 36-41

  Van Vulpen, M ^a   De Leeuw, A A C ^a   Raaymakers, B W ^a   Van Moorselaar, R J A ^a   Hofman, P ^a   Lagendijk, J J W ^a   Battermann, J J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Follow up; Hyperthermia; Hyperthermia dose; Prostate carcinoma; Radiotherapy; Regional interstitial

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTRODE; EVALUATION; FEASIBILITY STUDY; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 1642456605     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04551.x     Document Type: Article

References (30)

1. Zagars GK, Pollack A, Smith LG. Conventional external-beam radiation therapy alone or with androgen ablation for clinical stage III (T3NX/NO, MO) adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1999; 44: 809-19
2. Kuban DA, El-Mahdi AM, Schellhammer PF. Potential benefit of improved local tumour control in patients with prostatic carcinoma. Cancer 1995; 75: 2373-82
3. Bolla M, Gonzalez D, Warde P et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 1997; 337: 295-300
4. Zelefsky MJ, Leibel SA, Gaudin PB et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491-500
5. Ryu S, Brown SL, Kim SH et al. Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia. Int J Radiat Oncol Biol Phys 1996; 34: 133-8
6. Anscher MS, Samulski TV, Dodge RD et al. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 1059-65
7. Kalapurakal JA, Mittal BB, Sathiaseelan V. Re-irradiation and external hyperthermia in locally advanced radiation recurrent, hormone refractory prostate cancer: a preliminary report. Br J Radiol 2001; 74: 745-51
8. Van Vulpen M, De Leeuw JRJ, Van Gellekom M et al. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia. Int J Hyperthermia 2003; 19: 402-13
9. Prionas SD, Kapp DS, Goffinet DR et al. Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1994; 28: 151-62
10. Petrovich Z, Emami B, Kapp D et al. Regional hyperthermia in patients with recurrent genitourinary cancer. Am J Clin Oncol 1991; 14: 472-7
11. Hurwitz MD, Kaplan ID, Svensson GK et al. Feasibility and patient tolerance of a novel transrectal ultrasound hyperthermia system for treatment of prostate cancer. Int J Hyperthermia 2001; 17: 31-7
12. Algan O, Fosmire H, Hynynen K et al. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 2000; 89: 399-403
13. Van Vulpen M, De Leeuw AAC, Van de Kamer JB et al. Regional hyperthermia combined with radiotherapy for locally advanced prostate carcinoma, a feasibility study with special attention to the use of invasive thermometry. Int J Hyperthermia 2003; in press
14. Van Vulpen M, Raaymakers BW, Lagendijk JJW et al. 3D controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma, a feasibility study. Int J Radiat Oncol Biol Phys 2002; 53: 116-26
15. ICRU. Report no. 50. International Commission on Radiation Units and Measurements Prescribing, Recording, and Reporting Photon Beam Therapy. Washington, DC: International Commission on Radiation Units and Measurements, 1993
16. Van Vulpen M, Raaymakers BW, De Leeuw AAC et al. Prostate perfusion in patients with locally advanced prostate carcinoma treated with different hyperthermia techniques. J Urol 2002; 168: 1597-602
17. Oleson JR, Samulski TV, Leopold KA et al. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993; 25: 289-97
18. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787-800
19. Sneed PK, Stauffer PR, McDermott MW et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/-hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phy 1998; 40: 287-95
20. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997: 219-24
21. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus statement. Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997; 37: 1035-41
22. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statis Assoc 1958; 53: 457-81
23. Cox DR. Regression models and life tables. J Royal Stats Soc B 1972; 34: 187-220
24. Pilepich MV, Krall JM, al-Sarraf M et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma, a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 1995; 45: 616-23
25. Laverdiere J, Gomez JL, Cusan L et al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 37: 247-52
26. Emami B, Scott C, Perez CA et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumours. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys 1996; 34: 1097-104
27. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800-9
28. Samulski TV, Clegg ST. Letter to the Editor. International J Hyperthermia 1996; 12: 445-7
29. Litwin MS, Fitzpatrick JM, Fossa SD et al. Defining an international research agenda for quality of life in men with prostate cancer. Prostate 1999; 41: 58-67
30. Lubeck DP, Grossfeld GD, Carroll PR. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology 2001; 58: 94-100